Latest filing published 02 Mar 2018 for GlaxoSmithKline plc, €219k.
Insider track record
No signal scores available.
D Troy: trading record in brief
D Troy discloses dealings in GlaxoSmithKline plc to RNS (LSE). We count 3 filings; the first trade dates from 15 February 2018 and the latest from 1 March 2018.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 2 March 2018 with a share grant (€219k) in GlaxoSmithKline plc. Filings reach the RNS (LSE) feed a median of 1 day after the trade. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to D Troy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,349 shares@ US$36.31100.0% of flown/aISIN US37733W1053FCA-NSM:LSE20180302131115_13553137_20200330111428047_28817-11
- 12,400 shares0New York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:LSE20180216172944_13536899_20200330111412573_11179-6
- 66,334 shares0New York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:LSE20180216172538_13536896_20200330111412573_11182-9
3 of 3 declarations